Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Steve Jackson, PharmD
Nisha Joseph, MD
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
September 12, 2026
Seoul
EHA 2026: Long-Term Zanubrutinib Outcomes
Alessandra Tedeschi, MD
Molecular Profiling in mHSPC: Informing Treatment Selection
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Case: Implementing ADT Intensification in mHSPC
Targeting PTEN: Why It Matters
ADT Intensification: The Evidence You Can’t Afford to Miss
De Novo mHSPC: Recognizing the Patients Who Need More
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
Nicolas Girard, MD
Louise Lim, MD
Jacob Sands, MD
Stephanie McDonald, MSN, FNP-BC, AOCNP
Rising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
Addressing Oncology-Related Infertility Through Collaborative Care
Irene Su, MD, MSCE
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.